Alex Andrianopoulos

Alex Andrianopoulos

Chief Executive Officer at
Amorphology, Inc.
Health Technology
Technology Services
Electronic Technology

Profile

Currently, Alex Andrianopoulos is Chief Executive Officer at Amorphology, Inc. since 2023.
Also holds director positions at Kapteyn-Murnane Laboratories, Inc., Avvio Medical, Inc., Novosteo, Inc., Vivodyne, Inc., Mattiq, Inc., and NVasc, Inc. Since 2015, serves as Chief Research and Development Officer at Kairos Venture Investments LLC.
Formerly served as Director at Actuate Therapeutics, Inc.

Alex Andrianopoulos active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Private Equity Investor 01/10/2015
Chief Executive Officer 01/06/2023

Former positions of Alex Andrianopoulos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

41

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Electronic Technology

Health Technology

Health Technology

Finance

Non-Energy Minerals

Health Technology

Technology Services

Technology Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Alex Andrianopoulos